NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $36,000 | +80.0% | 424 | +78.9% | 0.06% | +100.0% |
| Q2 2017 | $20,000 | +17.6% | 237 | +1.7% | 0.03% | +33.3% |
| Q1 2017 | $17,000 | -29.2% | 233 | -30.7% | 0.02% | -40.0% |
| Q4 2016 | $24,000 | -11.1% | 336 | 0.0% | 0.04% | -16.7% |
| Q3 2016 | $27,000 | +8.0% | 336 | +10.5% | 0.05% | +20.0% |
| Q2 2016 | $25,000 | +4.2% | 304 | -7.3% | 0.04% | +11.1% |
| Q1 2016 | $24,000 | -54.7% | 328 | -46.5% | 0.04% | -52.0% |
| Q4 2015 | $53,000 | -5.4% | 613 | 0.0% | 0.08% | -3.8% |
| Q3 2015 | $56,000 | -6.7% | 613 | -0.3% | 0.08% | +13.0% |
| Q2 2015 | $60,000 | -4.8% | 615 | -4.2% | 0.07% | -9.2% |
| Q1 2015 | $63,000 | -57.4% | 642 | -59.7% | 0.08% | -55.6% |
| Q4 2014 | $148,000 | -21.3% | 1,592 | -20.1% | 0.17% | -29.6% |
| Q3 2014 | $188,000 | +51.6% | 1,992 | +44.9% | 0.24% | +35.8% |
| Q2 2014 | $124,000 | +287.5% | 1,375 | +266.7% | 0.18% | +237.7% |
| Q1 2014 | $32,000 | -60.0% | 375 | -62.5% | 0.05% | -56.2% |
| Q4 2013 | $80,000 | – | 1,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |